JOHN MCLAUGHLIN
CIK 1203240 · Former President and CEO · last filed 2026-01-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
34
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SNOA | Director | — | $1.09 | — | $0 | 4 | 2026-01-02 |
| Sonoma Pharmaceuticals, Inc. (SNOAW) Delisted | Director | 48,728 | — | — | $0 | 7 | 2018-06-01 |
| Sonoma Pharmaceuticals, Inc. (OCLSW) Delisted | Director | 7,999 | — | — | $0 | 1 | 2016-11-30 |
| Sonoma Pharmaceuticals, Inc. (OCLS) Delisted | Director | 6,576 | — | — | $0 | 10 | 2016-08-30 |
| Sonoma Pharmaceuticals, Inc. (OCLS.W) Delisted | Director | 17,878 | — | — | $0 | 5 | 2016-03-02 |
Recent Filings · Page 4 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2007-06-21 | — | Mixed | — | -$18.3K | |
| 2007-06-20 | — | Mixed | — | -$28.8K | |
| 2007-06-18 | — | Mixed | — | -$28.9K | |
| 2007-05-21 | — | Grant (A) | — | $0 |
Showing 31–34 of 34
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.